In vitro tumor models have provided important tools for cancer research and serve as low-cost screening platforms for drug therapies; however, cancer recurrence remains largely unchecked due to metastasis, which is the cause of the majority of cancer-related deaths. The need for an improved understanding of the progression and treatment of cancer has pushed for increased accuracy and physiological relevance of in vitro tumor models. This session welcomes speakers looking to address this need with their research.
Session Chair: DR MIRIAM DWEK
LEADER - CANCER RESEARCH GROUP
UNIVERSITY OF WESTMINSTER
My current research interests are in the area of cancer biomarker discovery, the development of new approaches for the in silico and in vitro study of breast cancer behaviour, diet and lifestyle aspects of breast cancer progression.
Call for Papers